Associations between the categories of the supplementary variable and the others used to build the map are described by interpreting the position of the supplementary categories in relation to the other categories’ position on the map. “
“Increasing numbers of travelers are visiting high altitude locations in the Andes. The epidemiology of acute mountain sickness (AMS) among tourists to high altitude DZNeP in South America is not well understood. A cross-sectional study to evaluate the epidemiology, pre-travel

preparation, and impact of AMS among travelers to Cusco, Peru (3,400 m) was performed at Cusco’s International Airport during June 2010. Foreign travelers, 18 years or older, staying 15 days or less, departing Cusco were invited to participate. Demographic, itinerary, and behavioral

data were collected. The Lake Louise Clinical score (LLCS) was used to assess AMS symptoms. In total, 991 travelers participated, median age 32 years Dasatinib in vivo (interquartile range 25–49), 55.5% female, 86.7% tourists, mostly from the United States (48.2%) and England (8.1%). Most (76.7%) flew from sea level to Cusco and 30.5% visited high altitude in the previous 2 months. Only 29.1% received AMS advice from a physician, 19% recalled advice on acetazolamide. Coca leaf products (62.8%) were used more often than acetazolamide (16.6%) for prevention. AMS was reported by 48.5% and 17.1% had severe AMS. One in five travelers with AMS altered their travel plans. Travelers older than 60 years, with recent high altitude exposure, who visited lower cities in their itinerary, or used acetazolamide were less likely to have AMS. Using coca leaf products was associated with

increased AMS frequency. AMS was common and adversely impacted plans of one in five travelers. Acetazolamide was Resminostat associated with decreased AMS but was prescribed infrequently. Other preventive measures were not associated with a decrease in AMS in this population. Pre-travel preparation was suboptimal. International travel to the South American Andes Mountains has doubled in the past 10 years. Tourist arrivals to Bolivia, Colombia, Ecuador, and Peru went from 2.5 million in 2000 to 6.2 million in 2009.[1] The majority of these tourists visited major cities above the high altitude mark of 2,500 m,[2] like La Paz (3,660 m) in Bolivia, Quito (2,850 m) in Ecuador, and Bogota (2,640 m) in Colombia. Cusco (3,400 m), in the south Andes of Peru, is a major tourist destination visited by over 1 million foreign tourists in 2008.[3] Of note, most tourists ascend to Cusco in flights departing at sea level and lasting less than 1 hour. Short-term exposure to high altitude is associated with acute mountain sickness (AMS), a common and usually self-limited illness.[2] In a prior survey of travelers to Cusco, AMS was as common as traveler’s diarrhea.